Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

ALMA - Pioneering Smart Lens to Revolutionize Eye Care

Objetivo

Nearly 5M people in the EU, the UK, and the US are affected by irregular corneas, a condition characterized by imperfections on the corneal surface. Irregular corneas disrupt the smooth, regular structure needed to focus light evenly onto the retina, leading to distorted or blurry vision. This condition can result from various causes, including diseases, injuries, or previous surgeries. Patients with irregular corneas often experience significant visual disturbances and may struggle with glare, halos, and night vision issues.
Treatment options range from spectacles and various contact lenses to more invasive procedures like corneal transplants. The current state-of-the-art solutions, including rigid scleral lenses, often fail to fully address higher order aberrations, leaving patients with persistent vision problems.
After 10+ years of research and breakthroughs in smart contact lens design, construction, and operation, Azalea has developed ALMA, the first patented autonomous and adaptable Smart Lens for patients with irregular corneas. This revolutionary solution integrates advanced light management technology into a scleral lens platform, featuring a dynamic light filter, a custom microchip, and a wireless smart case for charging and disinfection. ALMA provides improved visual quality, enhanced comfort, and real-time adaptation to environmental conditions, offering a new standard of care for patients with irregular corneas.
With EIC’s support, Azalea plans to conduct First-in-Human and pivotal clinical trials to obtain CE mark and FDA approvals for the commercialization of the ALMA Smart Lens. Our initial focus is on the irregular cornea market across Europe, the UK, and the US. This market encompasses a total addressable population of 614k patients with irregular corneas, representing a market opportunity of €3B. The project is expected to significantly impact Azalea, projecting €130M in revenues and reaching 135 employees within 5 years of commercialization.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2026-ACCELERATOR-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

AZALEA VISION
Aportación neta de la UEn
€ 2 498 825,00
Dirección
TECHNOLOGIEPARK-ZWIJNAARDE 122
9052 GAND
Bélgica
Pyme
Sí
Región
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos